Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genoil (GNOLF) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to $62005.0.

  • Genoil's Accumulated Expenses rose 10331.51% to $62005.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $62005.0, marking a year-over-year increase of 10331.51%. This contributed to the annual value of $38612.0 for FY2024, which is 27105.52% up from last year.
  • According to the latest figures from Q3 2025, Genoil's Accumulated Expenses is $62005.0, which was up 10331.51% from $53890.0 recorded in Q2 2025.
  • In the past 5 years, Genoil's Accumulated Expenses ranged from a high of $6.3 million in Q2 2023 and a low of $3945.0 during Q3 2023
  • In the last 5 years, Genoil's Accumulated Expenses had a median value of $1.2 million in 2021 and averaged $2.3 million.
  • In the last 5 years, Genoil's Accumulated Expenses crashed by 9991.6% in 2023 and then skyrocketed by 67305.45% in 2024.
  • Genoil's Accumulated Expenses (Quarter) stood at $4.1 million in 2021, then soared by 37.43% to $5.6 million in 2022, then plummeted by 99.82% to $10406.0 in 2023, then surged by 271.06% to $38612.0 in 2024, then soared by 60.58% to $62005.0 in 2025.
  • Its Accumulated Expenses was $62005.0 in Q3 2025, compared to $53890.0 in Q2 2025 and $46098.0 in Q1 2025.